Cargando…
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity
Genetic activation of hedgehog/glioma‐associated oncogene homolog (HH/GLI) signaling causes basal cell carcinoma (BCC), a very frequent nonmelanoma skin cancer. Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent developm...
Autores principales: | Grund‐Gröschke, Sandra, Ortner, Daniela, Szenes‐Nagy, Antal B., Zaborsky, Nadja, Weiss, Richard, Neureiter, Daniel, Wipplinger, Martin, Risch, Angela, Hammerl, Peter, Greil, Richard, Sibilia, Maria, Gratz, Iris K., Stoitzner, Patrizia, Aberger, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463314/ https://www.ncbi.nlm.nih.gov/pubmed/32615027 http://dx.doi.org/10.1002/1878-0261.12758 |
Ejemplares similares
-
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
por: Grund-Gröschke, Sandra, et al.
Publicado: (2019) -
Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog—GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition
por: Peer, Elisabeth, et al.
Publicado: (2021) -
An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma
por: Gruber, Wolfgang, et al.
Publicado: (2014) -
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report
por: Steiner, Markus, et al.
Publicado: (2021) -
Mouse models to decipher anti-tumor immunity
por: Parigger, Thomas, et al.
Publicado: (2019)